Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions

Expert Review of Neurotherapeutics

Volumn 11, Issue 9, 2011, Pages 1305-1313

  Shahrizaila, Nortina ^a   Yuki, Nobuhiro ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

antiganglioside antibodies; Fisher syndrome; Guillain Barr syndrome

Indexed keywords

AUTOANTIBODY; ECULIZUMAB; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ACUTE MOTOR AXON NEUROPATHY; ANTIBODY DETECTION; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE CLASSIFICATION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MOLECULAR MIMICRY; NEUROPATHY; PATHOGENESIS; PLASMAPHERESIS; REVIEW;

AUTOANTIBODIES; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; MILLER FISHER SYNDROME;

EID: 80052192517     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.114     Document Type: Review

References (94)

1. Guillain G, Barré JA, Strohl A. [Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes]. Bulletins et mémoires de la Société des Médecins des Hǒpitaux de Paris 40, 1462-1470 (1916).
2. McKhann GM, Cornblath DR, Griffin JW et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33(4), 333-342 (1993). (Pubitemid 23103964)
3. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255(2), 57-65 (1956).
4. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 56(8), 1104-1106 (2001). (Pubitemid 32336323)
5. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35(6), 691-711 (2007). (Pubitemid 46838749)
6. Ilyas AA, Willison HJ, Quarles RH et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23(5), 440-447 (1988).
7. Hadden RDM, Cornblath DR, Hughes RAC et al. Electrophysiological classification of Guillain-Barré syndrome: Clinical associations and outcome. Ann. Neurol. 44(5), 780-788 (1998). (Pubitemid 28516049)
8. Jacobs BC, van Doorn PA, Schmitz PIM et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40(2), 181-187 (1996).
9. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38(5), 809-816 (1995).
10. Hiraga A, Mori M, Ogawara K, Hattori T, Kuwabara S. Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes. Neurology 61(4), 471-474 (2003). (Pubitemid 37025362)
11. Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain 133(Pt 10), 2897-2908 (2010).
12. Ropper AH. Further regional variants of acute immune polyneuropathy: Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch. Neurol. 51(7), 671-675 (1994). (Pubitemid 24201885)
13. Hiraga A, Mori M, Ogawara K et al. Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 76(5), 719-722 (2005). (Pubitemid 40569686)
14. Asahina M, Kuwabara S, Suzuki A, Hattori T. Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome. Acta Neurol. Scand. 105(1), 44-50 (2002). (Pubitemid 34188269)
15. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 8(6), 528-539 (1985).
16. Asbury AK, McKhann GM. Changing views of Guillain-Barré syndrome. Ann. Neurol. 41(3), 287-288 (1997).
17. Hafer-Macko CE, Sheikh KA, Li CY et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39(5), 625-635 (1996). (Pubitemid 26143601)
18. Kusunoki S, Chiba A, Hitoshi S, Takizawa H, Kanazawa I. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 18(4), 409-413 (1995).
19. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107(1), 111-121 (1992).
20. Susuki K, Yuki N, Hirata K, Kuwabara S. Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome. J. Neurol. Sci. 195(2), 145-148 (2002). (Pubitemid 34202291)
21. Yako K, Kusunoki S, Kanazawa I. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. J. Neurol. Sci. 168(2), 85-89 (1999). (Pubitemid 29467424)
22. Yuki N, Tagawa Y, Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 70(1), 1-6 (1996). (Pubitemid 26323561)
23. Irie S, Saito T, Nakamura K et al. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J. Neuroimmunol. 68(1-2), 19-26 (1996). (Pubitemid 26279242)
24. Yuki N, Tagawa Y. Acute cytomegalovirus infection and IgM anti-GM2 antibody. J. Neurol. Sci. 154(1), 14-17 (1998). (Pubitemid 28123209)
25. Miyazaki T, Kusunoki S, Kaida K, Shiina M, Kanazawa I. Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b. Neurology 56(9), 1227-1229 (2001). (Pubitemid 32405723)
26. Ho TW, Mishu B, Li CY et al. Guillain-Barré syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118, 597-605 (1995).
27. Islam Z, Jacobs BC, van Belkum A et al. Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology 74(7), 581-587 (2010).
28. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 48(4), 624-631 (2000).
29. Capasso M, Caporale CM, Pomilio F, Gandolfi P, Lugaresi A, Uncini A. Acute motor conduction block neuropathy: Another Guillain-Barré syndrome variant. Neurology 61(5), 617-622 (2003). (Pubitemid 37082597)
30. Kaida K, Sonoo M, Ogawa G et al. GM1/GalNAc-GD1a complex: A target for pure motor Guillain-Barré syndrome. Neurology 71(21), 1683-1690 (2008).
31. Griffin JW, Li CY, Ho TW et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann. Neurol. 39(1), 17-28 (1996).
32. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40(12), 1900-1902 (1990).
33. Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15(8), 899-903 (1992).
34. Yuki N, Yamada M, Sato S et al. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 16(6), 642-647 (1993). (Pubitemid 23157336)
35. Ho TW, Willison HJ, Nachamkin I et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45(2), 168-173 (1999). (Pubitemid 29072362)
36. Kusunoki S, Chiba A, Kon K et al. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35(5), 570-576 (1994).
37. Ang CW, Yuki N, Jacobs BC et al. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Neurology 53(9), 2122-2127 (1999).
38. Kusunoki S, Iwamori M, Chiba A, Hitoshi S, Arita M, Kanazawa I. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology 47(1), 237-242 (1996). (Pubitemid 26243890)
39. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1a. J. Neuroimmunol. 74(1-2), 30-34 (1997). (Pubitemid 27128974)
40. Yuki N, Ang CW, Koga M et al. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside. Ann. Neurol. 47(3), 314-321 (2000). (Pubitemid 30141840)
41. Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T. Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J. Neurol. Sci. 210(1-2), 41-45 (2003). (Pubitemid 36539402)
42. Yuki N, Sato S, Miyatake T, Sugiyama K, Katagiri T, Sasaki H. Motoneuron-disease-like disorder after ganglioside therapy. Lancet 337(8749), 1109-1110 (1991).
43. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38(2), 218-224 (1995).
44. Yuki N, Taki T, Inagaki F et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178(5), 1771-1775 (1993). (Pubitemid 23318456)
45. Susuki K, Nishimoto Y, Yamada M et al. Acute motor axonal neuropathy rabbit model: Immune attack on nerve root axons. Ann. Neurol. 54(3), 383-388 (2003). (Pubitemid 37072042)
46. Yuki N, Yamada M, Koga M et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49(6), 712-720 (2001). (Pubitemid 32530237)
47. Yuki N, Susuki K, Koga M et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl Acad. Sci. USA 101(31), 11404-11409 (2004). (Pubitemid 39038359)
48. Susuki K, Rasband MN, Tohyama K et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 27(15), 3956-3967 (2007). (Pubitemid 46597169)
49. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barré syndrome in Taiwan: A clinical study of 167 patients. J. Neurol. Neurosurg. Psychiatry 63(4), 494-500 (1997).
50. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31(6), 677-679 (1992).
51. Ito M, Kuwabara S, Odaka M et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: Clinical analysis of 581 cases. J. Neurol. 255(5), 674-682 (2008).
52. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies. Neurology 43(10), 1911-1917 (1993). (Pubitemid 23318855)
53. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50(2), 159-165 (1994).
54. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43(2), 414-417 (1993). (Pubitemid 23060282)
55. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 745(1-2), 32-36 (1997). (Pubitemid 27055743)
56. Liu JX, Willison HJ, Pedrosa-Domellof F. Immunolocalisation of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest. Ophthalmol. Vis. Sci. 50(7), 3226-3232 (2009).
57. Koga M, Ang CW, Yuki N et al. Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The Netherlands. J. Neurol. Neurosurg. Psychiatry 70(5), 693-695 (2001). (Pubitemid 32398012)
58. Kimoto K, Koga M, Odaka M et al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 67(10), 1837-1843 (2006). (Pubitemid 44900763)
59. Koga M, Gilbert M, Li J et al. Antecedent infections in Fisher syndrome: A common pathogenesis of molecular mimicry. Neurology 64(9), 1605-1611 (2005). (Pubitemid 40617699)
60. Houliston RS, Koga M, Li J et al. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry 46(27), 8164-8171 (2007). (Pubitemid 47051652)
61. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 65(9), 1376-1381 (2005). (Pubitemid 41552764)
62. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol. 39(5), 668-672 (1996).
63. Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22(8), 1071-1074 (1999). (Pubitemid 29360252)
64. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch. Neurol. 43(11), 1150-1152 (1986). (Pubitemid 17174443)
65. Tatsumoto M, Odaka M, Hirata K, Yuki N. Isolated abducens nerve palsy as a regional variant of Guillain-Barré syndrome. J. Neurol. Sci. 243(1-2), 35-38 (2006).
66. Richter RB. The ataxic form of polyradiculoneuritis (Landry-Guillain- Barré syndrome): Clinical and pathologic observations. J. Neuropathol. Exp. Neurol. 21, 171-184 (1962).
67. Yuki N, Susuki K, Hirata K. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: Relation to Miller Fisher syndrome. Neurology 54(9), 1851-1853 (2000). (Pubitemid 30428417)
68. Notturno F, Caporale CM, Uncini A. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve 37(2), 265-268 (2008). (Pubitemid 351214176)
69. Yuki N, Susuki K, Hirata K. Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody. J. Neurol. Neurosurg. Psychiatry 69(1), 136-137 (2000). (Pubitemid 30410436)
70. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann. Neurol. 39(4), 424-431 (1996). (Pubitemid 26117997)
71. Takada K, Shimizu J, Kusunoki S. Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy. Exp. Neurol. 209(1), 279-283 (2008).
72. Ito M, Matsuno K, Sakumoto Y, Hirata K, Yuki N. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J. Neurol. Neurosurg. Psychiatry 82(3), 294-299 (2010).
73. Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis. Br. Med. J. 2(4723), 77-81 (1951).
74. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J. Neurol. Sci. 118(1), 83-87 (1993). (Pubitemid 23269971)
75. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch. Neurol. 64(10), 1519-1523 (2007). (Pubitemid 47572676)
76. O'Leary CP, Veitch J, Durward WF, Thomas AM, Rees JH, Willison HJ. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neuro. Neurosurg. Psychiatry 61(6), 649-651 (1996). (Pubitemid 27023349)
77. Koga M, Yoshino H, Morimatsu M, Yuki N. Anti-GT1a IgG in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 72(6), 767-771 (2002).
78. Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet 2(8099), 1100 (1978). (Pubitemid 9052892)
79. The Guillain-Barré syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35(8), 1096-1104 (1985).
80. Kuwabara S, Mori M, Ogawara K et al. Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibody. Muscle Nerve 24(1), 54-58 (2001). (Pubitemid 32038027)
81. Jacobs BC, Schmitz PI, van der Meché FG. Campylobacter jejuni infection and treatment for Guillain-Barré Syndrome. N. Engl. J. Med. 335(3), 208-209 (1996). (Pubitemid 26249464)
82. Nishimoto Y, Koga M, Kamijo M, Hirata K, Yuki N. Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration. Neurology 62(11), 1939-1944 (2004). (Pubitemid 38738200)
83. Buchwald B, Ahangari R, Weishaupt A, Toyka KV. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Ann. Neurol. 51(6), 673-680 (2002). (Pubitemid 34568844)
84. Zhang G, Lopez PH, Li CY et al. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: Implications for immune neuropathies. Brain 127(Pt 5), 1085-1100 (2004). (Pubitemid 38623044)
85. Halstead SK, Zitman FM, Humphreys PD et al. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131(Pt 5), 1197-1208 (2008).
86. Phongsisay V, Susuki K, Matsuno K et al. Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome. J. Neuroimmunol. 205(1-2), 101-104 (2008).
87. Kaida K, Kamakura K, Ogawa G et al. GD1b-specific antibody induces ataxia in Guillain-Barré syndrome. Neurology 71(3), 196-201 (2008).
88. Kaida K, Morita D, Kanzaki M et al. Anti-ganglioside complex antibodies associated with severe disability in GBS. J. Neuroimmunol. 182(1-2), 212-218 (2007). (Pubitemid 46026709)
89. Kuijf ML, Godschalk PC, Gilbert M et al. Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 188(1-2), 69-73 (2007). (Pubitemid 47095018)
90. Lopez PH, Zhang G, Bianchet MA, Schnaar RL, Sheikh KA. Structural requirements of anti-GD1a antibodies determine their target specificity. Brain 131(Pt 7), 1926-1939 (2008). (Pubitemid 351957448)
91. Griffin JW, Li CY, Macko C et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J. Neurocytol. 25(1), 33-51 (1996).
92. Buchwald B, Zhang G, Vogt-Eisele AK et al. Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol. Dis. 28(1), 113-121 (2007). (Pubitemid 47432904)
93. Lopez PH, Zhang G, Zhang J et al. Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. J. Neurosci. 30(28), 9533-9541 (2010).
94. Uncini A, Yuki N. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes. Expert Rev. Neurother. 9(6), 869-994 (2009).